British scientists have created the first blood test for chronic fatigue syndrome.
According to inkorr.com: British researchers announced the development of the world’s first blood test that helps identify chronic fatigue syndrome, which was previously difficult to diagnose. Professor Dmytro Pshozhetsky noted that this innovation will allow for faster diagnosis and treatment initiation.
Study details
ME/CFS is a serious condition characterized by extreme fatigue that does not improve with rest. Our blood test is a simple and accurate way to confirm the diagnosis, helping patients receive the necessary support and treatment more quickly.
Researchers discovered unique patterns in the DNA structure of patients with ME/CFS that are not observed in healthy individuals. The test showed high effectiveness in detecting this condition, but additional studies are needed to confirm its accuracy before it can be implemented in practice.
Thus, the world’s first blood test for diagnosing chronic fatigue syndrome has been created, which can significantly simplify the process of detection and treatment of this serious illness.
This scientific breakthrough opens new possibilities for patients with ME/CFS. As experts note, accurate and rapid diagnosis is the first step towards effective therapy. With further research, the blood test may become the standard in the treatment of chronic fatigue syndrome, helping many people receive urgent care and improve their quality of life.
Read also
- On U.S. Independence Day, Honoring American Volunteers Who Died in Ukraine—Their Families Speak
- Poland and Ukraine Honor Their Fallen Together: Ceremony at the Mound for the Warriors Commemorates Heroes of 1920
- Water Usage for Street Cooling in Odessa: How Much Do Municipal Crews Spray During Heatwaves?
- 1994 Passport Booklets Still in Use: Ukrainians Urged to Upgrade Before Deadline
- Ukrainian Contract Soldiers Under 25 Can Now Secure Discharge: Key Conditions Explained
- Why Ukrainian Unity Holds the Key to the Future of Ukraine and Poland

